Tsantes, A.G.; Papadopoulos, D.V.; Trikoupis, I.G.; Goumenos, S.; Piovani, D.; Tsante, K.A.; Mavrogenis, A.F.; Vaiopoulos, A.G.; Koulouvaris, P.; Nikolopoulos, G.K.;
et al. The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown. J. Clin. Med. 2021, 10, 3397.
https://doi.org/10.3390/jcm10153397
AMA Style
Tsantes AG, Papadopoulos DV, Trikoupis IG, Goumenos S, Piovani D, Tsante KA, Mavrogenis AF, Vaiopoulos AG, Koulouvaris P, Nikolopoulos GK,
et al. The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown. Journal of Clinical Medicine. 2021; 10(15):3397.
https://doi.org/10.3390/jcm10153397
Chicago/Turabian Style
Tsantes, Andreas G., Dimitrios V. Papadopoulos, Ioannis G. Trikoupis, Stavros Goumenos, Daniele Piovani, Konstantina A. Tsante, Andreas F. Mavrogenis, Aristeidis G. Vaiopoulos, Panagiotis Koulouvaris, Georgios K. Nikolopoulos,
and et al. 2021. "The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown" Journal of Clinical Medicine 10, no. 15: 3397.
https://doi.org/10.3390/jcm10153397
APA Style
Tsantes, A. G., Papadopoulos, D. V., Trikoupis, I. G., Goumenos, S., Piovani, D., Tsante, K. A., Mavrogenis, A. F., Vaiopoulos, A. G., Koulouvaris, P., Nikolopoulos, G. K., Papagelopoulos, P. J., Bonovas, S., & Tsantes, A. E.
(2021). The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown. Journal of Clinical Medicine, 10(15), 3397.
https://doi.org/10.3390/jcm10153397
